Menu
Your Cart

Maxigesic NZ

Product Compare0
Quickview
Maxigesic PE Cold Flu Sinus Relief Tablets Maxigesic PE Cold Flu Sinus Relief Tablets
-50 %
Brand: Maxigesic NZ Model: Maxigesic PE Cold Flu Sinus Relief Tablets
Maxigesic PE Cold Flu Sinus Relief Tablets
Maxigesic PE Cold Flu Sinus Relief TabletsFor the temporary relief of cold and flu symptoms including:Fever & inflammationHeadache & sore throatBlocked & runny noseDeveloped in New Zealand to help combat colds and flus.This specific combination is designed to allow the maximum daily dose..
NZ$9.99 NZ$19.90
Add to Cart
Add to Wish List Compare this Product
Quickview
Maxigesic Double Action Pain Relief Tablets 20s Maxigesic Double Action Pain Relief Tablets 20s
Brand: Maxigesic NZ Model: Maxigesic
Maxigesic Double Action Pain Relief Tablets 20s
Maxigesic Double Action Pain Relief Tablets 20sDouble action relief from pain and feverUse: For relief of pain and reduction of fever and inflammation.Reduces fever and the discomfort associated with fever. For temporary relief of pain associated with:headachemigraine headachetension headachesinus p..
NZ$9.90
Add to Cart
Add to Wish List Compare this Product
Showing 1 to 2 of 2 (1 Pages)
MAXIGESIC® is a unique patented combination of paracetamol 500mg and ibuprofen 150mg. These tried and trusted active ingredients work together in combination to provide better pain relief than paracetamol or ibuprofen alone, and reduce fever and inflammation.
MAXIGESIC® was developed as a better alternative for pain relief than other combination painkiller products, particularly those containing codeine.
MAXIGESIC® is clinically proven to reduce pain levels by at least 32% more than a full daily OTC dose of either paracetamol or ibuprofen alone.
The only combination analgesic that provides the maximum daily OTC dosage of paracetamol 4000mg and ibuprofen 1200mg, if required.
Simple, flexible dose of 1–2 tablets every 4–6 hours as required, up to a maximum 8 tablets per day.
MAXIGESIC® was invented and developed in New Zealand by Hartley Atkinson, pharmacologist and founder of AFT Pharmaceuticals. Introduced in New Zealand in 2009, this world-first specific combination analgesic now has license agreements in over 125 countries around the world.